Search Ontology:
ChEBI

cyproterone acetate

Term ID
CHEBI:50743
Synonyms
  • (1beta,2beta)-17-(acetyloxy)-6-chloro-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione
  • (1R,3aS,3bR,7aR,8aS,8bS,8cS,10aS)-1-acetyl-5-chloro-8b,10a-dimethyl-7-oxo-1,2,3,3a,3b,7,7a,8,8a,8b,8c,9,10,10a-tetradecahydrocyclopenta[a]cyclopropa[g]phenanthren-1-yl acetate
  • 1,2alpha-methylene-6-chloro-17alpha-acetoxy-4,6-pregnadiene-3,20-dione
  • 1,2alpha-methylene-6-chloro-Delta(4,6)-pregnadien-17alpha-ol-3,20-dione acetate
  • 1,2alpha-methylene-6-chloro-pregna-4,6-diene-3,20-dione 17alpha-acetate
  • 17alpha-acetoxy-6-chloro-1alpha,2alpha-methylenepregna-4,6-diene-3,20-dione
  • 6-chloro-1,2alpha-methylene-17alpha-hydroxy-Delta(6)-progesterone acetate
  • 6-chloro-1,2alpha-methylene-6-dehydro-17alpha-hydroxyprogesterone acetate
  • 6-chloro-17-hydroxy-1alpha,2alpha-methylenepregna-4,6-diene-3,20-dione acetate
  • 6-chloro-3,20-dioxo-1beta,2beta-dihydro-3'H-cyclopropa[1,2]pregna-4,6-dien-17-yl acetate
  • acetic acid (8R,9S,10S,13S,14S,17R)-17-acetyl-6-(S)-chloro-10,13-dimethyl-3-(R)-oxo-1,2,3,8,9,10,11,12,13,14,15,16,17,20-tetradecahydro-cyclopropa[1,2]cyclopenta[a]phenanthren-17-yl ester
  • Androcur
  • Cyprostat
  • Cyproterone 17-O-acetate
  • cyproterone 17alpha-acetate
  • CYPROTERONE ACETATE
  • SH 714
(all 17)
Definition
A steroid ester resulting from the formal condensation of the carboxy group of acetic acid with the 17-hydroxy group of cyproterone. It is an antiandrogenic drug which has recently been recognized to promote the occurrence and growth of intracranial meningiomas.
References
(all 38)
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
has_functional_parent
has_role
Phenotype
Phenotype resulting from cyproterone acetate
Phenotype where environments contain cyproterone acetate
Phenotype modified by environments containing cyproterone acetate
Phenotype affecting cyproterone acetate
Human Disease Model
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.